Less competitive drug makers will likely collapse

Pharmaceutical business sources say that from now on, less competitive pharmaceutical firms will not only see their businesses decline but also face shutdowns as well under the currently deteriorating business conditions aggressive assault of leading pharmaceutical firms in clinics, introduction of new drug pricing policy, free trade accord between Korea and United States and new global good m...